Investors Research Corp’s Bristol-Myers Squibb BMY Stock Holding History

Investors Research Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$497K	Sell	8,628 -156	-2%	-$8.96K	0.09%	173
2026 Q1	$533K	Buy	8,784 +28	+0.3%	+$1.63K	0.1%	172
2025 Q4	$472K	Hold	8,756	–	–	0.09%	211
2025 Q3	$395K	Hold	8,756	–	–	0.07%	225
2025 Q2	$405K	Hold	8,756	–	–	0.08%	221
2025 Q1	$534K	Sell	8,756 -413	-5%	-$24.1K	0.12%	180
2024 Q4	$519K	Hold	9,169	–	–	0.11%	191
2024 Q3	$474K	Buy	9,169 +607	+7%	+$28.5K	0.1%	209
2024 Q2	$356K	Buy	8,562 +7,775	+988%	+$348K	0.08%	247
2024 Q1	$42.7K	Hold	787	–	–	0.01%	520
2023 Q4	$40.4K	Hold	787	–	–	0.01%	535
2023 Q3	$45.7K	Hold	787	–	–	0.01%	526
2023 Q2	$50.3K	Hold	787	–	–	0.01%	512
2023 Q1	$54.5K	Hold	787	–	–	0.01%	518
2022 Q4	$56.6K	Hold	787	–	–	0.02%	496
2022 Q3	$56K	Hold	787	–	–	0.02%	473
2022 Q2	$61K	Hold	787	–	–	0.02%	481
2022 Q1	$57K	Hold	787	–	–	0.02%	498
2021 Q4	$49K	Hold	787	–	–	0.01%	525
2021 Q3	$47K	Hold	787	–	–	0.02%	529
2021 Q2	$53K	Hold	787	–	–	0.02%	513
2021 Q1	$50K	Hold	787	–	–	0.02%	511
2020 Q4	$49K	Hold	787	–	–	0.02%	546
2020 Q3	$47K	Hold	787	–	–	0.02%	514
2020 Q2	$46K	Hold	787	–	–	0.02%	503
2020 Q1	$44K	Buy	787 +18	+2%	+$1.1K	0.03%	467
2019 Q4	$49K	Buy	769 +300	+64%	+$17.2K	0.02%	524
2019 Q3	$24K	Buy	+469	New	+$22K	0.01%	651

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Investors Research Corp's BMY Position: Q2 2026 in Review

Investors Research Corp reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q2 2026, selling an estimated $8.96K and leaving 8,628 shares worth $497K. The position accounts for 0.09% of the portfolio, ranked #173.

Investors Research Corp first reported a position in BMY in Q3 2019 and has held it in 28 quarters since. The position peaked at $534K in Q1 2025. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Investors Research Corp held 8,628 shares of Bristol-Myers Squibb worth $497K as of Q2 2026.
Investors Research Corp sold 156 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.96K.
Bristol-Myers Squibb made up 0.09% of Investors Research Corp's portfolio in Q2 2026, its #173 holding.
Investors Research Corp first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 28 quarters since.
Investors Research Corp's Bristol-Myers Squibb position peaked at $534K in Q1 2025.
888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.